StockData
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. (JSPR) income statement

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$11.52+1.18 (+11.41%)

Close on Nov 18, 2026Market cap $383.32MP/E –Yield –

See a number that looks wrong?